https://www.selleckchem.com/pr....oducts/milademetan.h
The aim of the study was to compare the performance of narrow diameter implants in patients with uncontrolled diabetes mellitus type 2 (T2DM) and normo-glycemic individuals during the first 12 months after implant loading. In 16 T2DM patients with HbA1C 6.5% (test group) and 16 normo-glycemic patients (HbA1C 6.0%; control group), one to two narrow diameter tissue level implants were placed in the posterior maxilla or mandible. After 3-month lasting integration period, implants were loaded by fixed dentures. The clinical pa
Like
Comment
Share
